Connecticut legislature passes pricing transparency bill

The Connecticut state Senate unanimously passed a bill to increase disclosure and reporting requirements for drug companies, PBMs, insurance companies and insurers. Connecticut’s House of Representatives unanimously passed the bill last week. If signed by Connecticut Governor Dannel Malloy, the legislation would take effect Jan. 1, 2020.

The bill, H.B. 5384, would establish an Office of Health Strategy (OHS) and require drug companies to justify to the office any drug price increases of more than 20% in one year or 50% over three years...